Skip to content

Chronic Periodontitis in Critically Ill Patients: Diagnosis and Epidemiology

Chronic Periodontitis in Critically Ill Patients: Diagnosis and Epidemiology

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02672384
Acronym
CP-ICU
Enrollment
100
Registered
2016-02-03
Start date
2017-01-20
Completion date
2018-10-14
Last updated
2018-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Periodontitis, Intensive Care Unit

Keywords

Intensive care unit, Invasive mechanical ventilation, Chronic periodontitis, Point of Care P. gingivalis test

Brief summary

This study evaluates the diagnostic performances of Point of Care P. gingivalis test in saliva with serum IgG P. gingivalis, in reference to dental examination as a gold standard in patients hospitalised in intensive care unit (ICU)

Detailed description

Chronic Periodontitis (CP) is a common but under diagnosed chronic infection and inflammation of the periodontal tissue. Porphyromonas gingivalis is one of the most common pathogens associated with CP. In patients hospitalised in Intensive Care Unit (ICU), P. gingivalis has been reported to be associated with Ventilator-Associated Pneumonia (VAP). This pilot study evaluate an easily accessible method the Point of care P. gingivalis tests on saliva and detection of antibodies against P. gingivalis in sera (already validated to diagnose CP in the general population) to dental examination as a gold standard, in ICU patients. A biobank from critically ill patients will be establish for future oral health research in this patient population: for about 50 patients with both samples available, at enrolment and at day 5 +/-2 days after enrolment. Oral pathogens of different sites (tongue, saliva, dental plaque, internal jaw) at enrolment and at day 5 +/- 2 days after enrolment. Samples of periodontal pocket will be collected only for patients diagnosed with CP. When patients will have a pulmonary sample performed in routine, pulmonary sample will also be stored. Plasma and sera will also be taken at enrolment and stored for further research on P. gingivalis and inflammation in ICU patients Patients will be enrolled and will be contacted after 3 months.

Interventions

PROCEDUREDental examination and a point of care P. gingivalis test (Denka Seiken Co (Japan) )

Dental examination Study exams (oral and blood sample collection)

Sponsors

Bayer
CollaboratorINDUSTRY
University Hospital, Brest
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient aged 18 years or older * Admitted to medical or surgical intensive care unit * Invasive mechanical ventilation for an anticipated duration of at least 48 hours

Exclusion criteria

* Edentulous * Known to be pregnant * ICU stay\<48 hours * High risk of infectious endocarditis * Patient under guardianship

Design outcomes

Primary

MeasureTime frameDescription
Result (positive/negative) of the point-of-care P. gingivalis test in saliva and P. gingivalis antibodies in seraone dayP. gingivalis test in saliva and P. gingivalis antibodies in sera

Secondary

MeasureTime frameDescription
Number of patient with discrepancies in findings of dental exam and point of care P. gingivalis test combined90 daysmeasure of discrepancies in findings of dental exam and point of care P. gingivalis test combined
Mortality at 90 days after intubation90 daysMortality
Ratio of enrolled patients/eligible patientsone yearcompare listing of enrolled patients and eligible patients
Incidence of VAP(Ventilator-Associated Pneumonia)90 daysVAP(Ventilator-Associated Pneumonia)
Recruitment rateone yearRecruitment rate
Incidence of CP (Chronic periodontitis) in mechanically ventilated patients90 daysCP (Chronic periodontitis) measure

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026